TNF and juvenile idiopathic arthritis: Our results showed that the mean age of children with JIA assigned to the anti-TNF biologics group (mean, 10.54 years) were significantly younger than the other two groups, namely, biologics-naïve MTX group with mean age at 11.22 and both MTX- and biologics-naive group, 11.55 (Table 3).